APA (7th ed.) Citation

Steffens, F., Wessels, F., Hetjens, S., Carl, N., Nitschke, K., Uysal, D., . . . Neuberger, M. (2025). Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): Results from a German real-world cohort. International urology and nephrology, 57(7), . https://doi.org/10.1007/s11255-025-04389-2

Chicago Style (17th ed.) Citation

Steffens, Felix, et al. "Prognostic Factors for Overall Survival in Castration-resistant Metastatic Prostate Cancer Treated with Docetaxel (MeProCSS): Results from a German Real-world Cohort." International Urology and Nephrology 57, no. 7 (2025). https://doi.org/10.1007/s11255-025-04389-2.

MLA (9th ed.) Citation

Steffens, Felix, et al. "Prognostic Factors for Overall Survival in Castration-resistant Metastatic Prostate Cancer Treated with Docetaxel (MeProCSS): Results from a German Real-world Cohort." International Urology and Nephrology, vol. 57, no. 7, 2025, https://doi.org/10.1007/s11255-025-04389-2.